Lanean...

SGLT2i: beyond the glucose-lowering effect

Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of glucose-lowering drug that can reduce blood glucose by inhibiting its reabsorption in proximal tubules and by promoting urinary glucose excretion. SGLT2i are widely used in the clinical treatment of type 2 diabetes mellitus (T2DM)....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cardiovasc Diabetol
Egile Nagusiak: Ni, Lihua, Yuan, Cheng, Chen, Guopeng, Zhang, Changjiang, Wu, Xiaoyan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320582/
https://ncbi.nlm.nih.gov/pubmed/32590982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01071-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!